About Us

Entheogen is a private corporation with an exclusive global patent to a drug with positive initial clinical results for severe vascular headaches and with no toxicity or negative side effects identified to date. Entheogen’s 2-Bromo-LSD, known as BOL-148 (“BOL”), may prove to be the single most effective treatment for cluster headache. Our mission is to develop exciting new drugs using our international network of researchers and empowering them to bring products like this to market.